{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/666798550e8c9a001297522a/67119e380c127cea5112f248?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Investing in Innovation: Femtech and Women’s Health Funding With Rachel Bartholomew","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/666798550e8c9a001297522a/1729288414599-3ea3051b-9dca-42c6-9a80-bdec30dcc6ba.jpeg?height=200","description":"<p>In this episode of <em>\"me-search,\"</em> JT speaks with Rachel Bartholomew&nbsp;founder of Hyivy, Femtech Canada, and Femtech Across Borders.</p><p><br></p><p> While recovering from a hysterectomy and lymphadenectomy, Rachel recognized the need for innovation in pelvic health. This led her to reinvent the 80-year-old dilator and create a holistic device designed to treat, monitor, track, and prevent various pelvic symptoms. This is how Hyivy was born.&nbsp;</p><p><br></p><p>JT and Rachel discuss the importance of femtech, women’s health funding, and the evolving and sometimes frustrating landscape of women’s health initiatives.</p>","author_name":"Herstasis®"}